Commentary

As Adjuvant Development Race Heats Up, New Databases Could Turn Japan into Global Vaccine Powerhouse

Lexicon

Conditional, Time-Limited Approval:
条件・期限付き承認

The Column

Sales Experience for Marketers Deceasing in Japan’s Pharma Industry

Archives

Novartis Slapped with 15 Day Biz Suspension over Flawed ADR Reporting(Feb.27)
PAFSC Second Committee Backs Approval of Celgene’s Pomalidomide(Feb.27)
MTPC Eyes Total Sales of Over 100 Billion Yen for Remicade, Simponi(Feb.27)
Takeda Launches Takecab, to Copromote with Otsuka(Feb.27)
Roundtable Discussion for Healthcare Policy for 2035 Kicked Off(Feb.27)

Most Read

1.
Bristol-Myers F...
2.
Gilead’s Sofosb...
3.
JPMA to Inform ...
4.
Shiozaki Says A...
5.
PAFSC Committee...

News Calendar